Sodium Chloride 0,9% USP

Premixed solutions in customized IV bags, sizes: 50, 100, 250, 500 and 1000 ml (one port, two ports, twist-off, luer valve)
Grifols Partnership is specialized in developing and manufacturing high quality sterile solutions in polypropylene flexible bags in different sizes to suit every need in both ...

Glass vials (5mL-50mL) Glass bottles (50mL-500mL)

Grifols Partnership is specialized in developing and manufacturing high quality sterile solutions in glass vials and bottles to suit every need in both the human and veterinary markets. 

Because diluent is as important as your API, Grifols offers you Water for Injection Drug Master File (DMF)

Grifols can provide a broad range of medical plastic solutions, including:

- Empty bags: in different types of materials and formats

- Medical device instruments and sub-assemblies: including device aggregations and instrument components (e.g.,robotic-arm related parts)

- Consumable co...

Grifols is strengthening its medical plastics proposition by leveraging the Murcia plant (located in Spain) available capacity and proven expertise in manufacturing medical plastic components, medical devices, and empty bags for healthcare applications.

Detailed information about Grifols Partnership's services, products and capabilities, offered to pharmaceutical companies. 

When the supply of 0.9% sodium chloride faltered, itexposed an uncomfortable truth: the fragility of globalpharmaceutical supply chains lies not only in rarebiologics or high-tech therapies, but in the cheapest,most basic medicines. Grifols usedthe crisis to showcase its Fleboflex® packaging technology. The polypropylene bags are free from PVC and plasticisers, reducing compatibility issues with certain drugs and aligning with sustainability targets. Because Grifols manufactures the bags itself from raw film reels to sterilised final product it can scale and adjust rapidly, without dependence on third-party suppliers.

Grifols has emphasised its commitment to expanding its parenteral CDMO services, predominantly in the small molecule injectable field. What strategies is the company adopting to reinforce its position in this market? And how does this align with the growing demand for small molecule injectable therapeutics?

Grifols expands its CDMO business by offering the manufacturing of medical plastic components

Our customers are happy customers! See what they say about our contract manufacturing services and what is like to trust their project in us!

Discover Grifols Partnership's services, products and capabilities offered to pharmaceutical companies. 

Read Pharma’s Almanac exclusive interview with Oriol Prat, Oriol Argemí and Marga Viñes, regarding trends in parenteral manufacturing, and how Grifols is maintaining its leadership in the small-volume parenteral manufacturing market.

0.9% Sodium Chloride Injection, USP, in Fleboflex® plastic container. Delivering a safe, reliable, and convenient IV solution.

Michael Howell, Site Director of Albumin Manufacturing at Grifols, speaks with Nigel Walker about how Grifols’ state-of-the-art facility in Dublin meets client demands in this new era in healthcare. They also discuss how risk assessment plays a major role in Grifols' success with customers.

Drug candidates are becoming increasingly complex as manufacturers continue to focus on niche and personalized medicines. Contract development and manufacturing organizations with process and capacity, flexibility, and wide-ranging expertise in small-volume GMP manufacturing are needed to support efforts by pharma companies to rapidly bring these specialized products to the market.

Extensive process understanding is required to ensure the consistent manufacture of high-quality sterile parenteral products. At Grifols, our use of state-of-the-art automated aseptic processing systems, including form-fill-seal (FFS) technology, ensures control with minimal human intervention.

Combining the focus on parenteral with the expertise of an established pharmaceutical leader, the contract manufacturing business is agile and flexible in its service to companies outsourcing the development and manufacture of added value injectable drugs.

Watch Pharma’s Almanac exclusive interview with Oriol Prat, Oriol Argemí and Marga Viñes, about trends in parenteral manufacturing, and how Grifols is maintaining its leadership in the small-volume parenteral manufacturing market.

Have you ever wondered what Grifols sites around the world are like? This aerial tour video provides a great visual perspective of various sites. Take two and a half minutes to watch it and see our sites around the world.

Grifols Partnership, your CDMO for filling vials. Because diluent is as important as your API.

Complete information about our products and services

Watch Neil Owens' interview, President and Chief Operations Officer at Medicure Inc about their experience working with Grifols Partnership.

In this exclusive interview, Marga Viñes, Senior Business Development Manager for
Contract Manufacturing and Carla Mössinger, Business Development Manager for IV Solutions & Contract Manufacturing answer questions about  the quality, flexibility, and efficiency of Grifols Partnership CDMO services.

- Empty bags: in different types of materials and formats- Medical device instruments (surgical devices, medical device aggregations...)
- Consumable components (MTUs, twist-off, connectors, adapters, holders,plastic parts for IVD, pipette tips, racks...)